Since the advent of biological agents for the treatment of BD, much attention has been paid to anti-TNF-α agents; however, there is an increasing number of biologics that target more or other cytokines, including IL-1 and IL-6 [45]. The gene discussed is IL6; the disease is Behcet disease.